Jeffrey D. Esko

42.1k total citations · 13 hit papers
318 papers, 31.7k citations indexed

About

Jeffrey D. Esko is a scholar working on Molecular Biology, Cell Biology and Organic Chemistry. According to data from OpenAlex, Jeffrey D. Esko has authored 318 papers receiving a total of 31.7k indexed citations (citations by other indexed papers that have themselves been cited), including 220 papers in Molecular Biology, 188 papers in Cell Biology and 69 papers in Organic Chemistry. Recurrent topics in Jeffrey D. Esko's work include Proteoglycans and glycosaminoglycans research (170 papers), Glycosylation and Glycoproteins Research (148 papers) and Carbohydrate Chemistry and Synthesis (68 papers). Jeffrey D. Esko is often cited by papers focused on Proteoglycans and glycosaminoglycans research (170 papers), Glycosylation and Glycoproteins Research (148 papers) and Carbohydrate Chemistry and Synthesis (68 papers). Jeffrey D. Esko collaborates with scholars based in United States, Germany and Sweden. Jeffrey D. Esko's co-authors include Ulf Lindahl, Mark M. Fuster, Scott B. Selleck, Joseph R. Bishop, Manuela Schuksz, Ajit Varki, Lianchun Wang, Ding Xu, Avner Yayon and Philip Leder and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Jeffrey D. Esko

316 papers receiving 31.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

1991 2.1k citations Jeffrey D. Esko et al. profile →
Essentials of Glycobiology

1999 2.0k citations Jeffrey D. Esko et al. profile →
Heparan sulphate proteoglycans fine-tune mammalian physiology

2007 1.3k citations Joseph R. Bishop, Manuela Schuksz et al. profile →
Order Out of Chaos: Assembly of Ligand Binding Sites in Heparan Sulfate

2002 1.2k citations Jeffrey D. Esko et al. Annual Review of Biochemistry profile →
Heparan Sulfate Proteoglycans

2011 1.1k citations William C. Lamanna, Jeffrey D. Esko et al. profile →
The sweet and sour of cancer: glycans as novel therapeutic targets

2005 1.1k citations Jeffrey D. Esko et al. profile →
A Novel Role for 3-O-Sulfated Heparan Sulfate in Herpes Simplex Virus 1 Entry

1999 881 citations Jeffrey D. Esko, Patricia G. Spear et al. profile →
Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate

1997 841 citations Jeffrey D. Esko et al. profile →
Molecular diversity of heparan sulfate

2001 731 citations Jeffrey D. Esko, Ulf Lindahl profile →
Molecular diversity of heparan sulfate

2001 714 citations Jeffrey D. Esko, Ulf Lindahl profile →
Demystifying Heparan Sulfate–Protein Interactions

2014 596 citations Ding Xu, Jeffrey D. Esko Annual Review of Biochemistry profile →
Animal cell mutants defective in glycosaminoglycan biosynthesis.

1985 517 citations Jeffrey D. Esko et al. Proceedings of the National Academy of Sciences profile →
Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development

2015 324 citations Philip L.S.M. Gordts, Jeffrey D. Esko et al. profile →

Peers

Countries citing papers authored by Jeffrey D. Esko

Since Specialization

Citations

This map shows the geographic impact of Jeffrey D. Esko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey D. Esko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey D. Esko more than expected).

Fields of papers citing papers by Jeffrey D. Esko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey D. Esko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey D. Esko. The network helps show where Jeffrey D. Esko may publish in the future.

Co-authorship network of co-authors of Jeffrey D. Esko

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey D. Esko. A scholar is included among the top collaborators of Jeffrey D. Esko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey D. Esko. Jeffrey D. Esko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chondroitin sulfate enhances the barrier function of basement membrane assembled by heparan sulfate 2022 ·Development ·Chenqi Tao, (unknown), Jen-Zen Chuang, Yihua Wu, Steven E. Brooks, Jeffrey D. Esko, Ching-Hwa Sung, Xin Zhang	6
2	Dissecting structure-function of 3-O-sulfated heparin and engineered heparan sulfates 2021 ·Science Advances ·Richard Karlsson, Pradeep Chopra, (unknown), Zhang Yang, Sergey Y. Vakhrushev, Thomas Mandel Clausen, Chelsea D. Painter, Gergő Péter Szekeres, Yen‐Hsi Chen, Daniel R. Sandoval, Lars Hestbjerg Hansen, Jeffrey D. Esko, Kevin Pagel, Douglas P. Dyer, Jeremy E. Turnbull, Henrik Clausen, Geert‐Jan Boons, Rebecca L. Miller	40
3	Shortening heparan sulfate chains prolongs survival and reduces parenchymal plaques in prion disease caused by mobile, ADAM10-cleaved prions 2019 ·Acta Neuropathologica ·Patricia Aguilar‐Calvo, Alejandro M. Sevillano, (unknown), Katrin Soldau, Daniel R. Sandoval, Hermann C. Altmeppen, Luise Linsenmeier, Donald Pizzo, Michael D. Geschwind, Henry Sánchez, Brian S. Appleby, Mark L. Cohen, Jiri Safar, Steven D. Edland, Markus Glatzel, K. Peter R. Nilsson, Jeffrey D. Esko, Christina J. Sigurdson	18
4	Hepatic heparan sulfate is a master regulator of hepcidin expression and iron homeostasis in human hepatocytes and mice 2019 ·Journal of Biological Chemistry ·Maura Poli, (unknown), Michela Asperti, (unknown), Magdalena Gryzik, (unknown), Philip L.S.M. Gordts, Paolo Arosio, Jeffrey D. Esko	17
5	Loss of Corneal Epithelial Heparan Sulfate Leads to Corneal Degeneration and Impaired Wound Healing 2015 ·Investigative Ophthalmology & Visual Science ·Vivien J. Coulson‐Thomas, (unknown), (unknown), Yvette M. Coulson‐Thomas, Yu Yamaguchi, Jeffrey D. Esko, Chia‐Yang Liu, Winston W.‐Y. Kao	40
6	Xylose phosphorylation functions as a molecular switch to regulate proteoglycan biosynthesis 2014 ·Proceedings of the National Academy of Sciences ·Jianzhong Wen, Junyu Xiao, Meghdad Rahdar, Biswa Choudhury, Jixin Cui, Gregory S. Taylor, Jeffrey D. Esko, Jack E. Dixon	88
7	Demystifying Heparan Sulfate–Protein Interactions breakdown → 2014 ·Annual Review of Biochemistry ·Ding Xu, Jeffrey D. Esko	596
8	Arylsulfatase G inactivation causes loss of heparan sulfate 3- O -sulfatase activity and mucopolysaccharidosis in mice 2012 ·Proceedings of the National Academy of Sciences ·(unknown), William C. Lamanna, Roger Lawrence, Markus Daμμe, Stijn Stroobants, (unknown), Ina Kalus, Marc‐André Frese, Torben Lübke, Renate Lüllmann‐Rauch, Rudi D’Hooge, Jeffrey D. Esko, Thomas Dierks	55
9	N-Sulfation of Heparan Sulfate Regulates Early Branching Events in the Developing Mammary Gland 2012 ·Journal of Biological Chemistry ·Kevin T. Bush, Brett E. Crawford, (unknown), (unknown), Jeffrey D. Esko, Sanjay K. Nigám	15
10	Lacrimal Gland Development and Fgf10-Fgfr2b Signaling Are Controlled by 2-O- and 6-O-sulfated Heparan Sulfate 2011 ·Journal of Biological Chemistry ·Xiuxia Qu, Christian Carbe, Chenqi Tao, (unknown), Roger Lawrence, Toin H. Van Kuppevelt, Wellington V. Cardoso, Kay Grobe, Jeffrey D. Esko, Xin Zhang	65
11	Inhibitory Peptides of the Sulfotransferase Domain of the Heparan Sulfate Enzyme, N-Deacetylase-N-sulfotransferase-1 2010 ·Journal of Biological Chemistry ·Tarsis F. Gesteira, Vivien J. Coulson‐Thomas, (unknown), Vitor Oliveira, Bryan E. Thacker, María A. Juliano, Renata Pasqualini, Wadih Arap, Ivarne L.S. Tersariol, Helena B. Nader, Jeffrey D. Esko, Maria Aparecida da Silva Pinhal	26
12	Repulsive axon guidance molecule Slit3 is a novel angiogenic factor 2009 ·Blood ·Bing Zhang, Ursula M. Dietrich, Jian-Guo Geng, Roy Bicknell, Jeffrey D. Esko, Lianchun Wang	120
13	Deoxygenated Disaccharide Analogs as Specific Inhibitors of β1–4-Galactosyltransferase 1 and Selectin-mediated Tumor Metastasis 2008 ·Journal of Biological Chemistry ·Jillian R. Brown, Feng Yang, Anjana Sinha, Boopathy Ramakrishnan, Yitzhak Tor, Pradman K. Qasba, Jeffrey D. Esko	35
14	Guanidinylated Neomycin Delivers Large, Bioactive Cargo into Cells through a Heparan Sulfate-dependent Pathway 2007 ·Journal of Biological Chemistry ·(unknown), (unknown), Manuela Schuksz, Brett E. Crawford, Jeffrey D. Esko, Yitzhak Tor	62
15	Identification of novel chondroitin proteoglycans in Caenorhabditis elegans : embryonic cell division depends on CPG-1 and CPG-2 2006 ·The Journal of Cell Biology ·Sara K. Olson, Joseph R. Bishop, John R. Yates, Karen Oegema, Jeffrey D. Esko	96
16	Ndst1 is Required for FGF Signaling in Early Lens Development 2006 ·Investigative Ophthalmology & Visual Science ·(unknown), Yi Pan, (unknown), Jeffrey D. Esko, Kay Grobe	1
17	Partial purification and substrate specificity of heparan sulfate α-N-acetylglucosaminyltransferase I: synthesis, NMR spectroscopic characterization and in vitro assays of two aryl tetrasaccharides 1997 ·Glycobiology ·Timothy A. Fritz, (unknown), Jeffrey D. Esko, N. Rama Krishna	16
18	Sulphated and undersulphated heparan sulphate proteoglycans in a Chinese hamster ovary cell mutant defective in N-sulphotransferase 1994 ·Biochemical Journal ·Karen J. Bame, Zhang Li, Gregory David, Jeffrey D. Esko	17
19	Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. 1992 ·The Journal of Cell Biology ·M. Shieh, Darrell WuDunn, Rebecca I. Montgomery, Jeffrey D. Esko, Patricia G. Spear	453
20	Biosynthesis of heparan sulfate. Coordination of polymer-modification reactions in a Chinese hamster ovary cell mutant defective in N-sulfotransferase 1991 ·Journal of Biological Chemistry ·Karen J. Bame, Kerstin Lidholt, Ulf Lindahl, Jeffrey D. Esko	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact